Search

You searched for "prostate cancer"

247 results found
The Journal of Urology cover image with Online Exclusive stamp

Trade-offs between risks and benefits of localised prostate cancer treatments – the COMPARE study

4 September 2020 | | URO - Urologic Oncology
We know little about the trade-offs men make when considering the oncological and functional outcomes of individual treatment options for localised prostate cancer, and decisions are often influenced by physician opinion. The likely compromised functional results are viewed as a...

Does empowering men on active surveillance for prostate cancer improve patient compliance and reduce conversion to treatment?

4 November 2025 | | URO - Core Urology, URO - Urologic Oncology
Active surveillance is a major treatment option for patients with favourable prognosis prostate cancer, such as those regarded as Cambridge Prognostic Group (CPG) 1 and 2 [1]. The rationale for this management strategy is the lack of survival benefit from...

Prostate Scotland launches updated resource to support men considering active surveillance for early prostate cancer

15 April 2026 | Urology News, Charities
Prostate Scotland has launched an updated patient information booklet focusing on active surveillance. The resource is designed for men newly diagnosed with localised prostate cancer, helping them to understand active surveillance as a management option and supporting informed discussions with...

Prostate Cancer Vaccine Research Launched in Surrey

3 September 2025
In September 2025, The Prostate Project, a Guildford-based volunteer-led charity, will launch a £250,000 campaign to raise funds for a prostate cancer research project widely anticipated to be ‘game-changing’. Work has begun to develop a vaccine to prevent the return...

Prostate Cancer UK Clinical Champions Programme

26 November 2024 | Research & Development, Charities, Awards, Conferences & Anniversaries
Prostate Cancer UK have opened applications for their award-winning Clinical Champions Programme.

RSM (Royal Society of Medicine) Complexity and Complications: Navigating Advanced Prostate Cancer

21 November 2025
This year’s RSM Cancer Day will focus on the evolving management of prostate cancer. With emerging evidence supporting radical prostatectomy in oligometastatic disease, the programme will examine patient selection, treatment strategies, and the latest advances for managing advanced-stage cases.

The postcode lottery costing men with prostate cancer years of life

14 October 2025 | Charities, Research & Development
Nearly a third of men miss out on lifesaving treatments for prostate cancer – raising to more than half in worst-hit areas Prostate cancer can be cured if found early, but 31% of men diagnosed with aggressive but curable prostate...

Prostate cancer: Black men more likely to be diagnosed at later stages

9 January 2025 | Charities, Research & Development
Latest data shows Black men have higher rates of stage 3 or stage 4 prostate cancer diagnoses compared with white men. Black men diagnosed at a later stage in their 60s are 14% less likely to get NICE approved treatment...

New £1.9M drug trial could delay relapse for prostate cancer patients

5 November 2025
A new drug could keep cancer under control for longer for men with advanced prostate cancer and will be tested in a new trial funded with £1.9 million from Prostate Cancer UK. Current treatments, like chemotherapy or hormone-targeting therapies, can...

Prostate Cancer

Prostate Cancer UK warns of over 8,600 ‘missing men’ as referrals drop by 52,000

5 May 2021 | Research & Development, COVID-19
The Covid-19 pandemic has led to around 52,000 (28%) fewer urgent prostate cancer referrals in England alone, according to statistics shared by Prostate Cancer UK. It’s estimated that more than 8,600 fewer men started treatment for...

New analysis by Prostate Cancer UK uncovers inequalities in mortality and refutes prevailing beliefs

13 November 2025
Prostate cancer mortality rates continue to be higher in Black men than white men, latest analysis reports. The disparity persists across all levels of deprivation, challenging beliefs that socioeconomic differences alone explain ethnic differences in outcomes. Even in the least...